Steris (STE) Cash from Investing Activities (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120.51% |
| Dec 31, 2025 | -11.55% |
| Sep 30, 2025 | 18.62% |
| Jun 30, 2025 | -55.38% |
| Mar 31, 2025 | 43.64% |
| Dec 31, 2024 | -17.66% |
| Sep 30, 2024 | -115.31% |
| Jun 30, 2024 | 819.40% |
| Mar 31, 2024 | 19.60% |
| Dec 31, 2023 | 80.38% |
| Sep 30, 2023 | -810.32% |
| Jun 30, 2023 | 14.16% |
| Mar 31, 2023 | 21.17% |
| Dec 31, 2022 | -0.50% |
| Sep 30, 2022 | 10.50% |
| Jun 30, 2022 | -216.93% |
| Mar 31, 2022 | 217.26% |
| Dec 31, 2021 | -3.90% |
| Sep 30, 2021 | 87.27% |
| Jun 30, 2021 | -410.36% |
| Mar 31, 2021 | 87.19% |
| Dec 31, 2020 | -1,900.56% |
| Sep 30, 2020 | 30.85% |
| Jun 30, 2020 | -11.68% |
| Mar 31, 2020 | 19.84% |
| Dec 31, 2019 | 26.32% |
| Sep 30, 2019 | -19.98% |
| Jun 30, 2019 | -14.45% |
| Mar 31, 2019 | -3.16% |
| Dec 31, 2018 | -114.50% |
| Sep 30, 2018 | 4.52% |